Metabolic and endocrine alterations in osteosarcoma patients
Open Access
- 1 August 1978
- Vol. 42 (2) , 603-610
- https://doi.org/10.1002/1097-0142(197808)42:2<603::aid-cncr2820420229>3.0.co;2-6
Abstract
Eighteen patients with primary osteosarcoma were studied for abnormal endocrinologic functions. Oral glucose tolerance tests revealed abnormal glucose, insulin, or growth hormone response curves in 78% of the study population. Elevated somatomedin values were noted in 72% of the patients tested. No significant deviations were observed in serum cortisol, estradiol, testosterone, follicle stimulating hormone, and luteinizing hormone levels. Likewise, lipid screening and 24 hour 17-hydroxy and 17-keto steroid excretion levels were normal. Statistically these derangements were unrelated, leading to the hypothesis that some additional factor or factors are present and responsible for the abnormalities noted. These deviations, found in association with primary osteosarcoma, constitute a new “paraneoplastic syndrome”.This publication has 25 references indexed in Scilit:
- HYPERADRENOCORTICISM AND ACTH‐RELEASING FACTORAnnals of the New York Academy of Sciences, 1974
- HYPERGLYCEMIAAnnals of the New York Academy of Sciences, 1974
- Time Course of Serum Estrogen and Luteinizing Hormone (LH) Concentrations During the Menstrual Cycle of the Rhesus MonkeyEndocrinology, 1971
- Stature and malignant tumors of bone in childhood and adolescenceCancer, 1967
- Osteogenic SarcomaJournal of Bone and Joint Surgery, 1967
- RADIOIMMUNOASSAY FOR HUMAN CHORIONIC GONADOTROPHIN AND LUTEINISING HORMONEThe Lancet, 1966
- Coated Charcoal Immunoassay of InsulinJournal of Clinical Endocrinology & Metabolism, 1965
- Osteogenic SarcomaJournal of Bone and Joint Surgery, 1957
- Diabetes and altered carbohydrate metabolism in patients with cancerCancer, 1956
- A CASE OF PLURIGLANDULAR SYNDROME: " DIABETES OF BEARDED WOMEN."The Lancet, 1928